Shopping Cart
Remove All
Your shopping cart is currently empty
Tagitanlimab (HBM-9167; KL-A167) is a humanized monoclonal antibody targeting PD-L1 that selectively blocks PD-L1-PD-1 interactions. It can be used to study recurrent or metastatic nasopharyngeal carcinoma (NPC).
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $247 | - | In Stock | |
| 5 mg | $647 | - | In Stock | |
| 10 mg | $987 | - | In Stock |
| Description | Tagitanlimab (HBM-9167; KL-A167) is a humanized monoclonal antibody targeting PD-L1 that selectively blocks PD-L1-PD-1 interactions. It can be used to study recurrent or metastatic nasopharyngeal carcinoma (NPC). |
| Synonyms | KL-A167, KLA167, HBM-9167, HBM9167 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Target | PD-L1 |
| Cas No. | 2417649-97-7 |
| Color | Transparent |
| Appearance | Liquid |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.